Status

PDF |Add To My Favorites |Track Bill | print page

AB-617 Stem Cell and Regenerative Therapy Regulation Advisory Group.(2019-2020)

Senate:
Assembly:1stCmt
Bill Status
AB-617
Mullin (A)
-
-
Stem Cell and Regenerative Therapy Regulation Advisory Group.
03/17/19
An act to add Chapter 3 (commencing with Section 125360) to Part 5.5 of Division 106 of the Health and Safety Code, and repeal Article 24.5 (commencing with Section 2524) of Chapter 5 of Division 2 of the Business and Professions Code, relating to public health. healing arts.
Assembly
05/01/19
Asm Health
04/23/19
Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar
(PASS) »» Ayes: 15; Noes: 0; Abstain: 0;

Type of Measure
Active Bill - In Committee Process
Seventy Percent Vote Required
Non-Appropriation
Fiscal Committee
Non-State-Mandated Local Program
Non-Urgency
Non-Tax levy
Last 5 History Actions
Date Action
05/16/19 In committee: Held under submission.
05/08/19 In committee: Set, first hearing. Referred to APPR. suspense file.
05/02/19 Re-referred to Com. on APPR.
05/01/19 From committee chair, with author's amendments: Amend, and re-refer to Com. on APPR. Read second time and amended.
04/24/19 From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (April 23). Re-referred to Com. on APPR.